Immune modulation in pemphigus vulgaris: role of CD28 and IL-10

J Immunol. 2000 Jan 1;164(1):522-9. doi: 10.4049/jimmunol.164.1.522.

Abstract

Pemphigus vulgaris (PV) is an autoimmune bullous skin disease characterized by Abs to the desmosomal cadherin desmoglein-3. Although the autoantibodies have been shown to be pathogenic, the role of the cellular immune system in the pathology of pemphigus-induced acantholysis is unclear. To further delineate the potential role of T cell-signaling pathways in the pathogenesis of PV, we performed passive transfer experiments with PV IgG in gene-targeted mutant mice. Our results demonstrated that CD28-deficient mice (lacking a costimulatory signal for T cell activation) are 5-fold more sensitive to the development of PV than wild-type mice. To evaluate whether the higher incidence of disease was due to an impairment in intercellular adhesion of keratinocytes, we performed an in vitro acantholysis, using CD28-/- mice keratinocytes. No alteration in in vitro adhesion was detected in CD28-/--type keratinocytes. Because the CD28 molecule plays a pivotal role in the induction of Th2 cytokines, we examined the levels of a prototypic Th2 cytokine (IL-10) in CD28-/- mice. Lower levels of IL-10 mRNA were found in lesions from CD28-/- mice. To determine whether pemphigus susceptibility in CD28-/- was related to IL-10 deficiency, we performed passive transfer experiments in IL-10-/- mice that demonstrated increased blisters compared with controls. To confirm that IL-10 is involved in the pathogenesis, rIL-10 was given with PV IgG. IL-10 significantly suppressed the disease activity. These data suggest a potential role of IL-10 in PV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acantholysis / genetics
  • Acantholysis / immunology
  • Acantholysis / pathology
  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / genetics
  • Adjuvants, Immunologic / physiology*
  • Adoptive Transfer
  • Animals
  • CD28 Antigens / genetics
  • CD28 Antigens / physiology*
  • Genetic Predisposition to Disease
  • Haplorhini
  • Immunoglobulin G / administration & dosage
  • Immunoglobulin G / biosynthesis
  • Immunoglobulin G / blood
  • Injections, Intradermal
  • Interleukin-10 / administration & dosage
  • Interleukin-10 / deficiency
  • Interleukin-10 / genetics
  • Interleukin-10 / physiology*
  • Keratinocytes / immunology
  • Keratinocytes / pathology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Pemphigus / genetics
  • Pemphigus / immunology*
  • Pemphigus / pathology
  • Pemphigus / prevention & control
  • RNA, Messenger / metabolism
  • Recombinant Proteins / administration & dosage
  • Skin / immunology

Substances

  • Adjuvants, Immunologic
  • CD28 Antigens
  • Immunoglobulin G
  • RNA, Messenger
  • Recombinant Proteins
  • Interleukin-10